Heparin-Binding EGF-like Growth Factor Decreases Neutrophil-Endothelial Cell Interactions

Journal of Surgical Research

Volumn 141, Issue 2, 2007, Pages 262-266

  Rocourt, Dorothy V ^a   Mehta, Veela B ^b   Wu, Dan ^b   Besner, Gail E ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

anoxia; endothelial cells; heparin binding EGF like growth factor; neutrophils; reoxygenation

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; PHOSPHATE BUFFERED SALINE;

ARTICLE; CELL ADHESION; CELL HYPOXIA; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE INJURY; INTESTINE ISCHEMIA; NEUTROPHIL; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; TIGHT JUNCTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADULT; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; EPIDERMAL GROWTH FACTOR; HUMANS; NEUTROPHILS;

EID: 34447252332     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.01.004     Document Type: Article

References (29)

1. Granger D.N., Benoit J.N., Suzuki M., et al. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 257 (1989) G683
2. Hayward R., and Lefer A.M. Time course of endothelial-neutrophil interaction in splanchnic artery ischemia-reperfusion. Am J Physiol 275 (1998) H2080
3. Granger D.N., and Kubes P. The microcirculation and inflammation: Modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55 (1994) 662
4. Smith C.W., Kishimoto T.K., Abbassi O., et al. Chemotactic factors regulate lectin adhesion molecule 1 (LECAM-1)-dependent neutrophil adhesion to cytokine-stimulated endothelial cells in vitro. J Clin Invest 87 (1991) 609
5. Panes J., and Granger D.N. Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114 (1998) 1066
6. Besner G., Higashiyama S., and Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul 1 (1990) 811
7. Higashiyama S., Abraham J.A., Miller J., et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936
8. Nishi E., Prat A., Hospital V., et al. N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J 20 (2001) 3342
9. Elenius K., Paul S., Allison G., et al. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J 16 (1997) 1268
10. Besner G.E., Whelton D., Crissman-Combs M.A., et al. Interaction of heparin-binding EGF-like growth factor (HB-EGF) with the epidermal growth factor receptor: Modulation by heparin, heparinase, or synthetic heparin-binding HB-EGF fragments. Growth Factors 7 (1992) 289
11. Davis-Fleischer K.M., and Besner G.E. Structure and function of heparin-binding EGF-like growth factor (HB-EGF). Front Biosci 3 (1998) 288
12. Xia G., Martin A.E., and Besner G.E. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg 38 (2003) 434
13. Kuhn M.A., Xia G., Mehta V.B., et al. Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal 4 (2002) 639
14. Mehta V.B., and Besner G.E. Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor. J Immunol 171 (2003) 6014
15. Rocourt D.V., Mehta V.B., and Besner G.E. Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res 139 (2007) 269
16. Oka S., Sasada M., Yamamoto K., et al. Nitric oxide derived from human umbilical vein endothelial cells inhibits transendothelial migration of neutrophils. Int J Hematol 81 (2005) 220
17. Sunder-Plassmann G., Hofbauer R., Sengoelge G., et al. Quantification of leukocyte migration: Improvement of a method. Immunol Invest 25 (1996) 49
18. Fuller E., Duckham C., and Wood E. Disruption of epithelial tight junctions by yeast enhances the paracellular delivery of a model protein. Pharm Res 24 (2007) 37
19. Minagar A., Long A., Ma T., et al. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10 (2003) 299
20. Taylor D.E. Revving the motor of multiple organ dysfunction syndrome. Gut dysfunction in ARDS and multiorgan failure. Respir Care Clin N Am 4 (1998) 611 vii
21. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 186 (2002) 8
22. Weyrich A.S., Buerke M., Albertine K.H., et al. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J Leukoc Biol 57 (1995) 45
23. Ma X.L., Weyrich A.S., Lefer D.J., et al. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72 (1993) 403
24. Xia G., Martin A.E., Michalsky M.P., et al. Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg 37 (2002) 1081 discussion 1081
25. El-Assal O.N., and Besner G.E. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 129 (2005) 609
26. Martin-Padura I., Lostaglio S., Schneemann M., et al. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142 (1998) 117
27. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15 (2003) 525
28. Naik U.P., and Eckfeld K. Junctional adhesion molecule 1 (JAM-1). J Biol Regul Homeost Agents 17 (2003) 341
29. Martin A.E., Luquette M.H., and Besner G.E. Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury. J Pediatr Surg 40 (2005) 1741